Influence of anaerobic conditions on vaginal microbiota recovery from bacterial vaginosis patients by Cereija, Tatiana Barros Reis et al.
Author version | accepted in Sex Transm Infect 
 
   Cereija et al. | 1  
 
Tatiana B Cereija, Joana Castro, Patrícia Alves, Nuno Cerca 
 
Influence of anaerobic conditions on vaginal microbiota recovery from bacterial 
vaginosis patients 
Institute for Biotechnology and Bioengineering (IBB), Centre for Biological Engineering, University of 
Minho, 4710-057 Braga, Portugal 
*Corresponding author: email: nunocerca@ceb.uminho.pt, Phone: (+351) 253604423, Fax (+351) 
253604429 
 
 
Bacterial vaginosis (BV) is one of the most common infections in women of reproductive age. 
Clinical studies have shown an association among BV and abnormal pregnancy, pelvic 
inflammatory disease and increased risk of sexually transmitted infections, including HIV. This 
disorder was first described in 1914 by Curtis as a “white discharge” syndrome and despite the 
decades of research we have only limited, and clearly not conclusive, evidence of microbial 
cause of BV, mechanism of disease and effective treatment. 
The development of molecular techniques such as Denaturing Gradient Gel Electrophoresis 
(DGGE) and DNA sequencing produced a clearer picture of the complexities of the vaginal 
microbiota. It has also become more apparent that none of the microorganisms already isolated 
from the vagina are likely to be the sole pathogen responsible for BV. Thus, improved 
knowledge of the relationship between different species of bacteria and their host is critical to a 
better understanding of both women’s health and illness. In order to comprehend the dynamic 
interaction between bacteria–bacteria and bacteria–host it becomes necessary to isolate 
bacteria from vaginal samples and to use them in in vitro and in vivo assays. The human vagina 
has a very specific environment regarding pH, nutrient availability and oxygen tension, being 
populated by a large range of bacteria from facultative to obligated anaerobic species. To 
isolate bacteria from such a complex niche, rich media should be used in order to promote the 
growth of different species. By using Columbia Agar (CBA) with 5% horse blood and by 
incubating at 37°C in the presence of 5%, 10% CO or in anaerobic condition generated by 
AnaeroGen
TM
 (Oxoid), we were able to recover different bacteria species, from each of the 
anaerobic conditions tested, from BV vaginal samples, including some species never reported, 
as far as we know, such as Brevibacterium ravenspurgense, Corynebacterium tuscaniense, 
Klebsiella variicola, Nosocomiicoccus ampullae, Staphylococcus warneri and Bacillus firmus.  
Despite the development of molecular methods and their unquestionable advantages in 
characterising the vaginal microbiota, classical bacteriology will nevertheless be required to 
elucidate the etiology of BV since the isolation of the pathogenic agent will be always required. 
Our findings revealed that slight differences in anaerobic conditions were crucial for the isolation 
of novel BV-associated organisms. Further in vitro studies of all the isolated bacteria will 
promote a better understanding of the dynamics of their interaction and will potentially reveal 
how BV develops and influences other sexual transmitted diseases. 
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